The perspective on psoriatic arthritis in Asia

Current Rheumatology Reports

Volumn 13, Issue 4, 2011, Pages 369-375

  Leung, Ying Ying ^a   Tam, Lai Shan ^a   Li, Edmund K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asia; Epidemiology; Premature atherosclerosis; Psoriatic arthritis

Indexed keywords

ARTERIAL WALL THICKNESS; ASIA; ATHEROSCLEROSIS; BODY MASS; CLINICAL FEATURE; COMORBIDITY; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; ETHNICITY; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HLA SYSTEM; HUMAN; INCIDENCE; INTERNATIONAL COOPERATION; PHENOTYPE; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REVIEW;

ARTHRITIS, PSORIATIC; ASIA; ATHEROSCLEROSIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; HEALTH CARE COSTS; HEALTH STATUS; HUMANS;

EID: 79960593998     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0183-9     Document Type: Review

References (49)

1. LS Tam YY Leung EK Li 2009 Psoriatic arthritis in Asia Rheumatol Oxf 48 1473 7 10.1093/rheumatology/kep230 This is a carefully written review and update on PsA in Asia
2. DD Gladman C Antoni P Mease DO Clegg P Nash 2005 Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 Suppl 2 ii14 7 15708927 10.1136/ard.2004.032482 (Pubitemid 40288513)
3. QY Zeng R Chen J Darmawan, et al. 2008 Rheumatic diseases in China Arthritis Res Ther 10 R17 18237382 10.1186/ar2368 This is a systematic review of epidemiologic studies in China from the 1980s to 2006. PsA was investigated as a subset of spondyloarthropathies in five studies (Pubitemid 351248283)
4. J Thumboo SN Tham YK Tay, et al. 1997 Patterns of psoriatic arthritis in Orientals J Rheumatol 24 1949 53 9330937 1:STN:280:DyaK2svnt1Sisg%3D%3D (Pubitemid 27431927)
5. S Hukuda M Minami T Saito, et al. 2001 Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society J Rheumatol 28 554 9 11296958 1:STN:280:DC%2BD3Mzot1ShsQ%3D%3D (Pubitemid 32202659)
6. F Jamshidi N Bouzari H Seirafi F Farnaghi A Firroz 2008 The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran Arch Iran Med 11 162 5 18298293 (Pubitemid 351425399)
7. HJ Baek CD Yoo KC Shin, et al. 2000 Spondylitis is the most common pattern of psoriatic arthritis in Korea Rheumatol Int 19 89 94 10776686 10.1007/s002960050109 1:STN:280:DC%2BD3c3js1Cntg%3D%3D (Pubitemid 30189839)
8. PV Prasad B Bikku PK Kaviarasan A Senthilnathan 2007 A clinical study of psoriatic arthropathy Indian J Dermatol Venereol Leprol 73 166 70 17558048 10.4103/0378-6323.32739 1:STN:280:DC%2BD2szksFKgsQ%3D%3D (Pubitemid 46918510)
9. X Fan S Yang LD Sun, et al. 2007 Comparison of clinical features of HLA-Cw 0602-positive and -negative psoriasis patients in a Han Chinese population Acta Derm Venereol 87 335 40 17598037 10.2340/00015555-0253
10. N Kundakci U Tursen MO Babiker E Gurgey 2002 The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients Int J Dermatol 41 220 4 12031031 10.1046/j.1365-4362.2002.01462.x (Pubitemid 34601126)
11. A Kawada T Tezuka Y Nakamizo, et al. 2003 A survey of psoriasis patients in Japan from 1982 to 2001 J Dermatol Sci 31 59 64 12615365 10.1016/S0923- 1811(02)00142-1 (Pubitemid 36286960)
12. HL Tey HL Ee AS Tan, et al. 2010 Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis J Dermatol 37 426 30 20536647 10.1111/j.1346-8138.2009.00745.x
13. W Taylor D Gladman P Helliwell CASPAR Study Group, et al. 2006 Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2665 73 16871531 10.1002/art.21972 (Pubitemid 44205029)
14. YY Leung LS Tam KW Ho, et al. 2010 Evaluation of the CASPAR criteria for psoriatic arthritis in the Chinese population Rheumatol Oxf 49 112 5 10.1093/rheumatology/kep348 This was the first validation study of CASPAR criteria in PsA of the Han Chinese in Asia
15. LS Tam B Tomlison TT Chu, et al. 2008 Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation Rheumatol Oxf 47 718 23 10.1093/rheumatology/ken090 This was a description of the association of PsA with traditional CV risk factors in the Chinese population; it suggested that PsA may be associated with obesity, hypertension, and insulin resistance due to a shared inflammatory pathway (Pubitemid 351619219)
16. T Yamamoto H Yokozeki K Nishioka 2005 Clinical analysis of 21 patients with psoriasis arthropathy J Dermatol 32 84 90 15906536 (Pubitemid 40410296)
17. M Moghaddassi F Shahram C Chams-Davatchi SR Najafizadeh F Davatchi 2009 Different aspects of psoriasis: analysis of 150 Iranian patients Arch Iran Med 12 279 83 19400606
18. CP Rajendran SG Ledge KP Rani R Madhavan 2003 Psoriatic arthritis J Assoc Physicians India 51 1065 8 15260390 1:STN:280:DC%2BD2czlslejtg%3D%3D (Pubitemid 41279815)
19. O Elkayam R Segal D Caspi 2004 Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis Rheumatol Int 24 93 7 12811505 10.1007/s00296-003-0325-0 1:CAS:528:DC%2BD2cXhsl2gt7s%3D (Pubitemid 38388751)
20. YG Tsai DM Chang SY Kuo, et al. 2003 Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis J Microbiol Immunol Infect 36 101 4 12886960
21. HT Liao KC Lin YT Chang, et al. 2008 Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients J Rheumatol 35 891 5 18381784
22. U Deesomchok T Tumrasvin 1993 Clinical comparison of patients with ankylosing spondylitis, Reiter's syndrome and psoriatic arthritis J Med Assoc Thai 76 61 70 8228701 1:STN:280:DyaK2c%2FksFehug%3D%3D
23. AM Al-Awadhi EA Hasan PN Sharma MZ Haider K Al-Saeid 2007 Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis Rheumatol Int 27 1119 23 17440728 10.1007/s00296-007-0349-y 1:CAS:528:DC%2BD2sXhtVSisLbK (Pubitemid 47373936)
24. J Feld G Weiss I Rosner, et al. 2008 Electrocardiographic findings in psoriatic arthritis: a case-controlled study J Rheumatol 35 2379 82 18843776 10.3899/jrheum.080314
25. H Saricaoglu S Güllülü E Bülbül Baskan J Cordan S Tunali 2003 Echocardiographic findings in subjects with psoriatic arthropathy J Eur Acad Dermatol Venereol 17 414 7 12834451 10.1046/j.1468-3083.2003.00748.x 1:STN:280:DC%2BD3szmsVGmtw%3D%3D (Pubitemid 36869304)
26. C Gonzalez-Juanatey E Amigo-Diaz JA Miranda-Filloy, et al. 2006 Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors Semin Arthritis Rheum 35 333 9 16616156 10.1016/j.semarthrit.2005. 12.002
27. DD Gladman PJ Mease V Strand, et al. 2007 Consensus on a core set of domains for psoriatic arthritis J Rheumatol 34 1167 70 17477480 (Pubitemid 46774868)
28. P Mease 2008 Assessment tools in psoriatic arthritis J Rheumatol 35 1426 30 18609738 This is a carefully written review article on the commonly used and validated assessment tools for PsA (Pubitemid 352000798)
29. SP McKenna LC Doward D Whalley, et al. 2004 Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis Ann Rheum Dis 63 162 9 14722205 10.1136/ard.2003.006296 1:STN:280:DC%2BD2c%2Fit1Omuw%3D%3D (Pubitemid 38122135)
30. YY Leung KW Ho TY Zhu LS Tam EW Kun EK Li 2010 Testing scaling assumptions, reliability and validity of Medical Outcomes Study Short-Form 36 Health Survey in psoriatic arthritis Rheumatol Oxf 49 1495 501 10.1093/rheumatology/keq112 This was a detailed evaluation of the psychometric properties of the Chinese version of SF-36 for Chinese patients with PsA
31. YY Leung LS Tam EW Kun KW Ho EK Li 2008 Comparing 4 functional indexes in psoriatic arthritis with axial or peripheral disease subgroups using Rasch analysis J Rheumatol 35 1613 21 18597399 This was one of the few studies to utilize item response theory to evaluate the psychometric properties of various measurements of physical functioning in PsA
32. YY Leung LS Tam EW Kun EK Li 2008 Impact of illness and variables associated with functional impairment in Chinese patients with psoriatic arthritis Clin Exp Rheumatol 26 820 6 19032814 1:STN:280:DC%2BD1cjmsFaisg%3D%3D
33. TY Zhu LS Tam YY Leung, et al. 2010 Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern J Rheumatol 37 1214 20 20360186 10.3899/jrheum.090988 This was the first cost evaluation study in PsA from Asia, which demonstrated a high financial burden associated with the disease. Axial PsA was noted to have double the indirect cost
34. YY Leung LS Tam KW Lee, et al. 2009 Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis Rheumatol Oxf 48 53 56 10.1093/rheumatology/ken410
35. DD Gladman 2008 Mortality in psoriatic arthritis Clin Exp Rheumatol 26 5 Suppl 51 S62 5 19026145 1:STN:280:DC%2BD1cfgtVOqug%3D%3D
36. O Kimhi D Caspi NM Bornstein, et al. 2007 Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis Semin Arthritis Rheum 36 203 9 17067658 10.1016/j.semarthrit.2006.09.001 (Pubitemid 46188476)
37. L Eder D Zisman M Barzilai, et al. 2008 Subclinical atherosclerosis in psoriatic arthritis: a case-control study J Rheumatol 35 877 82 18381785 This case-control study demonstrated that PsA status and other traditional CV risk factors were associated with high IMT and carotid plaques (Pubitemid 351747131)
38. LS Tam Q Shang EK Li, et al. 2008 Subclinical carotid atherosclerosis in patients with psoriatic arthritis Arthritis Rheum 59 1322 31 18759318 10.1002/art.24014 This was a study illustrating higher carotid IMT among Chinese PsA patients as compared with controls. Subclinical atherosclerosis was present in 35% of PsA patients despite a low CV risk according to FRS
39. •• Tam LS, Li EK, Shang Q, et al. Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study. Ann Rheum Dis. 2010 Jul 20. (Epub ahead of print). This is some preliminary evidence showing the reversal of subclinical atherosclerosis via treatment with TNF blockers in PsA patients.
40. •• Di Minno MN, Iervolino S, Peluso R, et al; on behalf of the CaRRDs study group. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-{alpha} blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol. 2011 Jan 6. (Epub ahead of print). This was an Italian study with an adequate sample size of 224 PsA patients (120 on TNF-α blockers and 104 on traditional disease-modifying antirheumatic drugs) compared with 305 controls, showing higher carotid IMT in disease-modifying antirheumatic drug-treated than in TNF-α blocker-treated PsA patients. It suggested treatment of inflammation in PsA may hamper the cascade that causes the increased vascular risk in PsA patients.
41. KC Duffin V Chandran DD Gladman, et al. 2008 Genetics of psoriasis and psoriatic arthritis: update and future direction J Rheumatol 35 1449 53 18609743 1:CAS:528:DC%2BD1cXpslajt7g%3D (Pubitemid 352000802)
42. DD O'Rielly P Rahman 2010 Where do we stand with the genetics of psoriatic arthritis? Curr Rheumatol Rep 12 300 8 20480402 10.1007/s11926-010- 0111-4 This is a useful review of up-to-date studies on the genetics of PsA and future prospects
43. V Chandran SP Raychaudhuri 2010 Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis J Autoimmun 34 J314 21 20034760 10.1016/j.jaut.2009.12.001 1:CAS:528:DC%2BC3cXjtVCksLk%3D This is a carefully written review on the epidemiology and genetics of psoriasis and PsA
44. Y Hamamoto H Tateno T Ishida M Muto 2000 Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients J Invest Dermatol 115 1162 4 11121160 10.1046/j.1523-1747.2000.0202a-5.x 1:CAS:528:DC%2BD3MXhtFartw%3D%3D (Pubitemid 32037469)
45. YT Chang CT Chou CW Yu, et al. 2007 Cytokine gene polymorphisms in Chinese patients with psoriasis Br J Dermatol 156 899 905 17388919 10.1111/j.1365-2133.2007.07820.x 1:CAS:528:DC%2BD2sXmt12rtr0%3D (Pubitemid 46642859)
46. CC Lan WC Tsai CS Wu CL Yu HS Yu 2004 Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthropathy Br J Dermatol 151 24 31 15270869 10.1111/j.1365-2133.2004.05890.x 1:CAS:528:DC%2BD2cXns1Sjsb4%3D (Pubitemid 39061277)
47. XJ Zhang W Huang S Yang, et al. 2009 Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 Nat Genet 41 205 210 19169255 10.1038/ng.310 1:CAS:528:DC%2BD1MXhtVWlsbc%3D This was the first GWAS conducted on psoriasis patients of Chinese ancestry
48. LD Sun H Cheng ZX Wang, et al. 2010 Association analyses identify six new psoriasis susceptibility loci in the Chinese population Nat Genet 42 1005 9 20953187 10.1038/ng.690 1:CAS:528:DC%2BC3cXhtlSgtbbF This was the extension GWAS study of a large sample size from China; results were compared with those from Germany and the United States. It highlighted again the heterogeneity of disease susceptibility between Chinese and European populations
49. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. Available at http://www.grappanetwork.org. Accessed January 2011.